Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Themis

Novartis building

Novartis’ vaccine sales decline ahead of GSK transfer

Only business not to show growth during second quarter of 2014

dengue fever mosquito

Sanofi’s dengue vaccine could debut in 2015

End in sight after 20-year wait for first effective vaccine

- PMLiVE

MSD’s Kate Tillett rewarded for healthcare comms excellence

Company's external affairs director wins at Communiqué 2014

- PMLiVE

Gardasil cleared for anal cancer prevention in EU

Adds to existing cervical cancer indication for Sanofi’s vaccine

- PMLiVE

Grunenthal to market MSD’s pain drug

Acquires rights to Arcoxia in several European countries

- PMLiVE

Interview: Bruno Strigini, MSD

MSD’s president, Europe and Canada, on how pharma is adapting to the market’s new reality

Novartis building

Novartis pays $16bn for GSK’s oncology portfolio

Swiss company strikes series of deals, including one to step away from vaccines

- PMLiVE

Integrating multichannel marketing

External forces are driving the need for pharma to use a greater variety of channels to reach customers

Novartis day

Novartis’ German poster campaign to raise vaccination awareness

In-house designed work aims to educate public about meningococcal bacteria

- PMLiVE

Pfizer’s meningitis vaccine ‘a breakthrough’

FDA to speed up review process for bivalent rLP2086

China flag thumb

China says hepatitis B vaccines not cause of infant deaths

But suspension on production remains in place

- PMLiVE

Astellas boosts vaccine ambitions

Forms alliance with ClearPath Development

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links